Andreas Meyerhans

Institució Catalana de Recerca i Estudis Avançats — Spain

Immunology and Microbiology · Life Sciences

48h-index9.0kcitations241works1.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(92), Immune Cell Function and Interaction(46), HIV/AIDS drug development and treatment(35), T-cell and B-cell Immunology(34), Cytomegalovirus and herpesvirus research(20)

Publications241 total

Dynamics and Sensitivity of the Lifecycle of Hepatitis B Virus
Pathogens·2026Open Access
Challenges in the Vaccination of HIV-Infected Individuals
Vaccines·2025Open Access
350 Long term survivors from Phase Ib-II trial of tumor-loaded monocyte-derived dendritic cell vaccination plus atezolizumab in ES-SCLC
Regular and Young Investigator Award Abstracts·2025Open Access
Quantifying the Inhibitory Efficacy of HIV-1 Therapeutic Interfering Particles at a Single CD4 T-Cell Resolution
Viruses·2025· 1 citedOpen Access
2779P Phase Ib-II trial of tumor-loaded monocyte-derived dendritic cell vaccination plus atezolizumab in ES-SCLC
Annals of Oncology·2025
Lessons from the European mpox outbreak: strengthening cohort research for future pandemic preparedness
Clinical Microbiology and Infection·2025Open Access
158P XCR1+ dendritic cell (DC) role in antitumoral response to anti PD-L1 antibody: Data from the phase Ib/II trial of DC vaccination in small cell lung cancer patients
Immuno-Oncology Technology·2024Open Access
Heterologous mRNA/MVA delivering trimeric-RBD as effective vaccination regimen against SARS-CoV-2: COVARNA Consortium
Emerging Microbes & Infections·2024· 7 citedOpen Access
Exploring the Therapeutic Potential of Defective Interfering Particles in Reducing the Replication of SARS-CoV-2
Mathematics·2024Open Access
Author Correction: Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium
npj Vaccines·2024· 1 citedOpen Access
Anti-PD-L1 Immunotherapy of Chronic Virus Infection Improves Virus Control without Augmenting Tissue Damage by Fibrosis
Viruses·2024· 1 citedOpen Access
Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium
npj Vaccines·2024· 11 citedOpen Access
Assessment of Human SARS CoV-2-Specific T-Cell Responses Elicited In Vitro by New Computationally Designed mRNA Immunogens (COVARNA)
Vaccines·2023Open Access
Differential kinetics of splenic CD169+ macrophage death is one underlying cause of virus infection fate regulation
Cell Death and Disease·2023· 5 citedOpen Access
Mathematical Model Predicting the Kinetics of Intracellular LCMV Replication
Mathematics·2023· 1 citedOpen Access
Immunogenicity and safety in pigs of PHH-1V, a SARS-CoV-2 RBD fusion heterodimer vaccine candidate
Vaccine·2023· 8 citedOpen Access
Preclinical evaluation of PHH-1V vaccine candidate against SARS-CoV-2 in non-human primates
iScience·2023· 7 citedOpen Access
Schlafen 12 restricts HIV-1 latency reversal by a codon-usage dependent post-transcriptional block in CD4+ T cells
Communications Biology·2023· 22 citedOpen Access
Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2
iScience·2023· 27 citedOpen Access
XCR1+ DCs are critical for T cell-mediated immunotherapy of chronic viral infections
Cell Reports·2023· 22 citedOpen Access
page 1 of 13Next →

Frequent Co-authors

Simon Wain–Hobson(14), Jean‐Pierre Vartanian(10), Martina Sester(8), Gennady Bocharov(6), Urban Sester(6), Juana Díez(6), Reinhard Maier(5), Javier P. Martínez(5), Uwe Plikat(5), Barbara C. Gärtner(4), Matthias Girndt(4), Hans Köhler(4), Birgitta Åsjö(3), Florenz Sasse(3), Nicoletta Scheller(3), Rui Pedro Galão(3), Bernhard Maier(3), Tanja Breinig(3), Rémi Cheynier(2), Eckart Meese(2)